Loading clinical trials...
Loading clinical trials...
Dinoprostone(propess) is commonly used for induction of labor in the pregnant women who has intact membrane after 38weeks of gestational age. The investigators study safety and efficacy of dinoprostone in the pregnant women with premature rupture of membrane or GA\<38weeks
Age
20 - 50 years
Sex
FEMALE
Healthy Volunteers
No
Seoul National University Hospital
Seoul, South Korea
Seoul Metropolitan Goverment Seoul National University Boramae Medical Center
Seoul, South Korea
Start Date
August 25, 2013
Primary Completion Date
August 14, 2018
Completion Date
April 4, 2019
Last Updated
March 24, 2020
189
ACTUAL participants
Propess insertion group
DRUG
Lead Sponsor
Seoul National University Hospital
NCT06803992
NCT07317674
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT02477085